Business Context and Reporting Period
This Form 8-K is a current report filed by Supernus Pharmaceuticals, Inc. on February 26, 2014, covering events reported on February 20 and February 25, 2014. The filing serves to announce upcoming corporate communications regarding the company's financial results for the fourth quarter and full year ended December 31, 2013, and a scheduled business update at an industry conference.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding the timing of future disclosures rather than a financial statement.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the scheduling of future events.
Guidance, Outlook, and Management Commentary
- Financial Results Announcement: Supernus expects to report financial results for the fourth quarter and full year ending December 31, 2013, after the market closes on March 12, 2014.
- Conference Call: A conference call and webcast to review 2013 financial results and provide a business update will be held on March 12, 2014.
- Industry Conference: Management will provide a business update on March 3, 2014, at the Cowen and Company Healthcare Conference in Boston, Massachusetts.
Investor Verification Checklist
- Verify the date and time of the earnings release and conference call scheduled for March 12, 2014.
- Confirm the details of the management presentation at the Cowen and Company Healthcare Conference on March 3, 2014.
- Review the attached press releases (Exhibits 99.1 and 99.2) for any additional context not summarized in the 8-K body.